Form 4: Jazz Pharmaceuticals CEO Bruce Cozadd Disposes of Shares to Cover Tax Obligations
SEC Form 4
Bruce Cozadd, Chairman and CEO of Jazz Pharmaceuticals, disposed of 22,436 ordinary shares on March 5, 2024, to satisfy tax obligations related to vesting restricted stock units.
Summary
- On March 5, 2024, Bruce C Cozadd, Chairman & CEO of Jazz Pharmaceuticals plc, disposed of 22,436 ordinary shares.
- The shares were withheld to cover tax obligations arising from the vesting of previously granted restricted stock units.
- The transaction was executed at a price of $117.53 per share.
- Following the transaction, Cozadd directly owns 429,809 ordinary shares.
Sentiment
Score: 6
Explanation: Neutral sentiment. The transaction is a routine disposal of shares to cover tax obligations, which is a normal part of executive compensation.
Industry Context
Executive share transactions are a common occurrence in publicly traded companies. Disposals to cover tax obligations related to vesting equity are typical and don't necessarily indicate a negative outlook on the company.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares by an executive to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Date of transaction: Disposal of shares to cover tax obligations. |
| 03/07/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.